Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Stem Cells for Cardiovascular Disease 2009

Published by: Select Biosciences Limited

Published: Jan. 1, 2009 - 106 Pages


Table of Contents


Chapter I. Executive Overview of the Space

Scope of this Market Report

Challenges in the Cellular Therapy Space

Cardiovascular Disease Market Segmentation

Cardiovascular Disease Market Opportunity

Embryonic Stem Cell (ESC) Differentiation into Multiple Cellular

Lineages

5-13

Chapter II. Mesenchymal Stem Cells (MSCs) for Regenerative

Medicine

MSCs: Definition and Properties

MSC Phenotype

Heart Cell Lineage Diversification

Pericytes: Tissue-Specific Progenitors

Mechanisms of MSC-mediated Tissue Repair

Fetal versus Adult MSCs

14-26

Chapter III. Stem Cells for Cardiovascular Disease: Technology

Landscape, Market Landscape, Clinical Trials Landscape

Cellular Therapy for Cardiovascular Diseases

Proposed Mechanisms of MSC-mediated Cardiovascular Repair

Potential Delivery Routes of MSC-based Cellular Therapy for

Cardiovascular Diseases

Safety Concerns with Stem Cell Therapy for Cardiovascular Disease

Quantitative Market Analysis of the Cardiovascular Regenerative

Medicine Space

Stem Cells for Cardiovascular Disease: Clinical Trials Landscape

27-65

Chapter IV. Stem Cells for Cardiovascular Disease: Selected

Industry Events and Companies in the Space

Selected Industry Events in Cardiovascular Cellular Therapy Space

Profiles of Companies in the Cardiovascular Cellular Therapy Space

66-93

Appendix I. Research Methodology Appendix

I-

1 to 2

Appendix II. Stem Cells for Cardiovascular Disease: Worldwide

Clinical Trials Details

Appendix

II-1 to 3

Appendix III. Cardiovascular Disease Patient Population Statistics Appendix

III-1 to 8

Abstract

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on the technical, market, and clinical trials aspects of stem cells being developed for addressing the opportunities in the cardio and vascular disease spaces. Major emphasis is placed on the various clinical applications of mesenchymal stem cells (MSCs)—a key stem cell lineage of paramount importance for regenerative medicine. A Major Focus of this Report is on the Market Landscape and Quantitative Market Trends in Cardiovascular Disease utilizing various types of stem cell classes/lineages. Another key focus of this report is on the various clinical trials either completed or in progress addressing different therapeutic areas across the cardiovascular diseases landscape. Extensive Worldwide Market Analyses Presented in this Report:


Results and Analyses from Stem Cells-Focused Market Surveys Administered to Large Respondent Pools of Industry Participants focused on Stem Cells—Qualitative and Quantitative Market Trends are Analyzed and Presented focusing on the cardiovascular disease spaces
Breakout of the Market by Types of Stem Cells Utilized and Application Areas—in various therapeutic segments of the cardiovascular disease therapeutics marketplace

Quantitative Breakout of various types of stem cells in research and clinical development for cardiovascular diseases

Breakout of the Market by Therapeutic/Disease Segments Addressed—in the various segments of the cardiovascular disease space

Worldwide Stem Cells-focused Clinical Trials for Cardiovascular Diseases
Qualitative and Quantitative Trends
Sponsoring Institutions/Companies
Types of Trials
Types of Cells Utilized
Clinical End-Points
Progress Reports
Competitive Landscape: Companies Focused on Developing Stem Cells-focused Cellular Therapies for Different Disease Areas in the Cardiovascular Space—Qualitative and Quantitative Analyses
Impact of Mesenchymal Stem Cells (MSCs) and other stem/progenitor cell types for mediating cardiovascular disease regenerative medicine
Mechanisms of action of MSCs in cardiovascular disease regenerative medicine
Delivery approaches for cellular therapy of cardiovascular diseases
Companies Profiled in This Market Report:

Aastrom Biosciences
Aldagen
Angioblast Systems
Arteriocyte
Athersys
Bioheart
Cytori
Geron
Medistem
Mytogen
Osiris Therapeutics
Pluristem
t2cure
TheraVitae

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2012